MSAIW Stock Price Chart
Daily OHLCV with technical indicators — pan, zoom, and customize your view
04
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance
Revenue, net income, margins and EPS trends
06
Revenue$6M2022-12-31 → 2025-12-31
EPS$-0.312022-12-31 → 2025-12-31
Free Cash Flow$-10M2023-12-31 → 2025-12-31
Net margin-141.7%2023-12-31 → 2025-12-31
Valuation & Ratios07–12
Valuation
P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
MSAIW
5Y avg
Peer Median
Verdict
P/E (TTM)
-0.0
·
·
·
P/S (TTM)
0.0
·
·
·
P/B (MRQ)
0.0
·
·
·
EV / EBITDA
2.0
·
·
·
Price / FCF (TTM)
-0.0
·
·
·
Price / Cash Flow (TTM)
-0.0
·
·
·
EV / Revenue
-4.4
·
·
·
EV / FCF
2.5
·
·
·
Price / Tangible Book
0.0
·
·
·
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability
Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
MSAIW
5Y avg
Peer Median
Verdict
Operating Margin (TTM)
-147.8%5Y avg ≈-289.3%
≈-289.3%
·
·
EBITDA Margin
-216.4%5Y avg ≈-289.3%
≈-289.3%
·
·
Pretax Margin (TTM)
-142.2%5Y avg ≈-304.8%
≈-304.8%
·
·
Net Profit Margin (TTM)
-141.7%5Y avg ≈-303.8%
≈-303.8%
·
·
ROA (TTM)
-37.0%5Y avg ≈-78.1%
≈-78.1%
·
·
ROE (TTM)
-46.5%5Y avg ≈30.8%
≈30.8%
·
·
ROIC
-37.4%5Y avg ≈1950.7%
≈1950.7%
·
·
Financial Health
Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
MSAIW
5Y avg
Peer Median
Verdict
Debt / Equity
0.0
·
·
·
Current Ratio (MRQ)
7.25Y avg ≈5.4
≈5.4
·
·
Quick Ratio
9.85Y avg ≈4.0
≈4.0
·
·
Growth
Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
MSAIW
5Y avg
Peer Median
Verdict
Revenue YoY
-25.0%5Y avg ≈-4.7%
≈-4.7%
·
·
Revenue CAGR 3Y
-8.6%
·
·
·
Per Share Metrics
EPS, book value per share, cash flow per share, dividend per share
Metric
5Y trend
MSAIW
5Y avg
Peer Median
Verdict
EPS (Diluted)
$-0.315Y avg ≈$-1.86
≈$-1.86
·
·
Revenue / Share
$0.155Y avg ≈$0.46
≈$0.46
·
·
Cash Flow / Share
$-0.215Y avg ≈$-0.57
≈$-0.57
·
·
Cash / Share
$0.305Y avg ≈$0.17
≈$0.17
·
·
Capital Efficiency
Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
MSAIW
5Y avg
Peer Median
Verdict
Asset Turnover
0.25Y avg ≈0.3
≈0.3
·
·
Receivables Turnover
4.45Y avg ≈3.9
≈3.9
·
·
Revenue / Employee
≈$264.3K
·
·
·
value · ≈ 5Y avg · industry median · verdict relative to median
Full Fundamentals
All metrics by year — income statement, balance sheet, cash flow
15
Income Statement14
Metric
Trend
2025
2024
2023
2022
Revenue
$6M
$7M
$5M
$7M
SG&A Expense
$11M
$16M
$8M
$14M
Operating Expenses
$14M
$21M
$23M
·
Operating Income
$-12M
$-19M
$-21M
$-12M
Interest Income
·
·
·
$2M
Other Non-op
$189.0K
$-1M
$-12.0K
$48.0K
Pretax Income
$-12M
$-22M
$-22M
$-12M
Income Tax
$-32.0K
$-465.0K
$208.0K
$1M
Net Income
$-12M
$-21M
$-22M
$-13M
EPS (Basic)
$-0.31
$-1.07
$-3.56
$-2.51
EPS (Diluted)
$-0.31
$-1.07
$-3.56
$-2.51
Shares (Basic)
37,348,581
20,119,161
6,257,476
5,292,384
Shares (Diluted)
37,348,581
20,119,161
6,257,476
5,292,384
EBITDA
$-12M
$-19M
$-22M
$-1M
Balance Sheet25
Metric
Trend
2025
2024
2023
2022
Cash & Equivalents
$24M
$4M
$1M
$654.0K
Receivables
$2M
$838.0K
$2M
$2M
Inventory
$4M
$4M
$7M
$10M
Prepaid Expense
$399.0K
$158.0K
$683.0K
$102.0K
Other Current Assets
$826.0K
$1M
$2M
$3M
Current Assets
$31M
$11M
$13M
$15M
PP&E (Net)
$4M
$4M
$3M
$2M
PP&E (Gross)
$7M
$6M
$5M
$3M
Accum. Depreciation
$3M
$2M
$2M
$1M
Other Non-current Assets
$129.0K
$0
$3.0K
$3.0K
Total Assets
$35M
$15M
$16M
$17M
Accounts Payable
$291.0K
$825.0K
$3M
$1M
Accrued Liabilities
$981.0K
$1M
$4M
$3M
Short-term Debt
$0
$172.0K
·
·
Current Liabilities
$3M
$3M
$11M
$7M
Deferred Tax
$33.0K
$80.0K
$18.0K
$90.0K
Total Liabilities
$3M
$3M
$17M
$26M
Long-term Debt
·
·
$8M
·
Total Debt
$0
·
·
·
Common Stock
·
$3.0K
$1.0K
$356
Paid-in Capital
$98M
$67M
$33M
$3M
Retained Earnings
$-66M
$-55M
$-33M
$-11M
Stockholders' Equity
$32M
$12M
$-268.0K
$-8M
Liabilities + Equity
$35M
$15M
$16M
$17M
Shares Outstanding
2,007,613
30,526,052
11,956,823
5,292,384
Cash Flow11
Metric
Trend
2025
2024
2023
2022
Stock-based Comp
$2M
$3M
$14M
$644.0K
Deferred Tax
$-47.0K
$62.0K
$-72.0K
$1M
Operating Cash Flow
$-8M
$-16M
$-5M
$-3M
CapEx
$2M
$3M
$2M
$2M
Investing Cash Flow
$-2M
$-3M
$-2M
$-2M
Stock Issued
·
$23M
$6M
·
Net Stock Activity
·
$23M
·
·
Financing Cash Flow
$30M
$22M
$7M
$2M
Net Change in Cash
$20M
$3M
$501.0K
$-3M
Taxes Paid
$73.0K
$2M
$6.0K
$33.0K
Free Cash Flow
$-10M
$-18M
$-6M
·
Profitability7
Metric
Trend
2025
2024
2023
2022
Operating Margin
-216.4%
-255.1%
-396.6%
·
Net Margin
-211.0%
-290.4%
-410.1%
·
Pretax Margin
-211.6%
-296.7%
-406.3%
·
EBITDA Margin
-216.4%
-255.1%
-396.6%
·
ROA
-46.0%
-135.0%
-131.6%
0.03%
ROE
-52.9%
-357.6%
525.4%
8.1%
ROIC
-37.4%
-150.4%
8110.5%
-120.0%
Liquidity & Solvency3
Metric
Trend
2025
2024
2023
2022
Current Ratio
11.7
3.5
1.2
·
Quick Ratio
9.8
1.7
0.3
·
Debt / Equity
0.0
·
·
·
Efficiency2
Metric
Trend
2025
2024
2023
2022
Asset Turnover
0.2
0.5
0.3
·
Receivables Turnover
4.4
4.5
2.8
·
Per Share5
Metric
Trend
2025
2024
2023
2022
Book Value / Share
$0.40
$0.40
$-0.02
$0.03
Revenue / Share
$0.15
$0.37
$0.87
·
Cash Flow / Share
$-0.21
$-0.77
$-0.73
·
Cash / Share
$0.30
$0.14
$0.10
$0.06
EPS (TTM)
$-0.31
$-1.07
$-3.56
$-2.51
Growth Rates2
Metric
Trend
2025
2024
2023
2022
Revenue YoY
-25.0%
36.3%
-25.3%
·
Revenue CAGR 3Y
-8.6%
·
·
·
Valuation (TTM)14
Metric
Trend
2025
2024
2023
2022
Revenue TTM
$6M
$7M
$5M
$7M
Net Income TTM
$-12M
$-21M
$-22M
$-13M
Market Cap
$7M
·
·
·
Enterprise Value
$-17M
·
·
·
P/E
-0.3
·
·
·
P/S
1.3
·
·
·
P/B
0.2
·
·
·
P / Tangible Book
0.2
·
·
·
P / Cash Flow
-0.9
·
·
·
P / FCF
-0.8
·
·
·
EV / EBITDA
1.4
·
·
·
EV / FCF
1.8
·
·
·
EV / Revenue
-3.1
·
·
·
Earnings Yield
-337.3%
·
·
·
Income Statement14
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Revenue
$2M
$2M
$1M
$2M
$1M
$1M
$1M
$2M
$2M
$2M
$2M
$1M
$1M
$980.0K
SG&A Expense
$3M
$3M
$2M
$2M
$3M
$4M
$4M
$6M
$3M
$3M
$-561.0K
$3M
$2M
$4M
Operating Expenses
$3M
$4M
$3M
$3M
$4M
$5M
$4M
$8M
$6M
$3M
·
·
·
·
Operating Income
$-3M
$-3M
$-2M
$-2M
$-3M
$-5M
$-3M
$-9M
$-5M
$-3M
$-13M
$-2M
$-3M
$-3M
Interest Income
·
·
·
·
·
·
·
·
·
·
·
$225.7K
$481.5K
$1M
Other Non-op
$-15.0K
$1.0K
$8.0K
$1.0K
$-5.0K
$185.0K
$-134.0K
$85.0K
$-978.0K
·
$879.9K
$-479.2K
$-429.6K
$17.0K
Pretax Income
$-2M
$-2M
$-2M
$-2M
$-3M
$-4M
$-3M
$-9M
$-6M
$-4M
$-17M
$-2M
$-641.0K
$-3M
Income Tax
$-14.0K
$33.0K
$-39.0K
$-11.0K
$10.0K
$8.0K
$-113.0K
$-395.0K
$12.0K
$31.0K
$219.0K
$-8.0K
$12.0K
$-15.0K
Net Income
$-2M
$-2M
$-2M
$-2M
$-3M
$-4M
$-3M
$-8M
$-6M
$-4M
$-17M
$-2M
$-653.0K
$-3M
EPS (Basic)
$-1.19
$-1.23
$-0.02
$-0.05
$-3.96
$-5.42
$0.07
$-0.34
$-0.47
$-0.33
$6.78
$-3.48
$-1.21
$-5.65
EPS (Diluted)
$-1.19
$-1.23
$-0.02
$-0.05
$-3.96
$-5.42
$0.07
$-0.34
$-0.47
$-0.33
$6.78
$-3.48
$-1.21
$-5.65
Shares (Basic)
2,069,434
2,012,241
·
34,495,208
838,785
818,141
·
24,268,186
13,681,678
11,966,928
·
539,271
539,271
514,946
Shares (Diluted)
2,069,434
2,012,241
·
34,495,208
838,785
818,141
·
24,268,186
13,681,678
11,966,928
·
539,271
539,271
514,946
EBITDA
$-3M
$-3M
·
$-2M
$-3M
$-5M
·
$-9M
$-5M
$-3M
·
$-409.5K
$-432.3K
$-520.2K
Balance Sheet25
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Cash & Equivalents
$21M
$23M
$24M
$1M
$3M
$5M
$4M
$9M
$234.0K
$491.0K
$1M
$27.9K
$255.5K
$14.0K
Receivables
$4M
$1M
$2M
$760.0K
$891.0K
$848.0K
$838.0K
$785.0K
$1M
$677.0K
$2M
·
·
·
Inventory
$3M
$4M
$4M
$4M
$4M
$5M
$4M
$4M
$6M
$6M
$7M
·
·
·
Prepaid Expense
$343.0K
$431.0K
$399.0K
$224.0K
$451.0K
$538.0K
$158.0K
$38.0K
$359.0K
$592.0K
$683.0K
$11.0K
$33.3K
$29.0K
Other Current Assets
$1M
$907.0K
$826.0K
$699.0K
$936.0K
$1M
$1M
$167.0K
$1M
$2M
$2M
·
·
·
Current Assets
$29M
$28M
$31M
$7M
$9M
$11M
$11M
$14M
$9M
$9M
$13M
$38.9K
$288.8K
$43.0K
PP&E (Net)
$4M
$4M
$4M
$4M
$4M
$4M
$4M
$3M
$4M
$3M
$3M
·
·
·
PP&E (Gross)
$7M
$7M
$7M
$7M
$7M
$6M
$6M
$5M
$6M
$6M
$5M
·
·
·
Accum. Depreciation
$4M
$3M
$3M
$3M
$2M
$2M
$2M
$2M
$2M
$2M
$2M
·
·
·
Other Non-current Assets
$181.0K
$202.0K
$129.0K
$55.0K
$14.0K
$37.0K
$0
·
$3.0K
$3.0K
$3.0K
·
·
·
Total Assets
$33M
$33M
$35M
$12M
$15M
$16M
$15M
$19M
$16M
$14M
$16M
$18M
$18M
$120M
Accounts Payable
$258.0K
$429.0K
$291.0K
$727.0K
$1M
$1M
$825.0K
$764.0K
$1M
$4M
$3M
·
·
·
Accrued Liabilities
$772.0K
$820.0K
$981.0K
$816.0K
$1M
$2M
$1M
$1M
$9M
$2M
$4M
·
·
·
Short-term Debt
·
·
$0
·
·
·
$172.0K
·
·
·
·
·
·
·
Current Liabilities
$4M
$2M
$3M
$3M
$5M
$3M
$3M
$3M
$15M
$11M
$11M
·
·
·
Capital Leases
·
·
·
·
·
·
·
$28.0K
·
·
·
·
·
·
Deferred Tax
$43.0K
$63.0K
$33.0K
$73.0K
$89.0K
$86.0K
$80.0K
$71.0K
$49.0K
$47.0K
$18.0K
·
·
·
Total Liabilities
$5M
$3M
$3M
$4M
$5M
$4M
$3M
$3M
$15M
$13M
$17M
$3M
$2M
$850.4K
Long-term Debt
·
·
·
·
·
·
·
·
$642.0K
$3M
·
·
·
·
Common Stock
·
·
$8.0K
$3.0K
$3.0K
$3.0K
$3.0K
$3.0K
$1.0K
$1.0K
$1.0K
$356
$356
$356
Paid-in Capital
$100M
$99M
$98M
$72M
$72M
$72M
$67M
$67M
$45M
$38M
$33M
·
·
·
Retained Earnings
$-71M
$-69M
$-66M
$-64M
$-62M
$-59M
$-55M
$-52M
$-43M
$-37M
$-33M
$-3M
$-1M
$-347.9K
Stockholders' Equity
$28M
$30M
$32M
$8M
$10M
$13M
$12M
$16M
$2M
$1M
$-268.0K
$-3M
$-1M
$-347.5K
Liabilities + Equity
$33M
$33M
$35M
$12M
$15M
$16M
$15M
$19M
$16M
$14M
$16M
$18M
$18M
$120M
Shares Outstanding
2,205,648
2,012,293
80,304,531
34,711,465
34,073,852
32,957,641
30,526,052
30,441,203
13,869,744
12,926,296
11,956,823
·
·
·
Cash Flow10
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Stock-based Comp
$187.0K
$182.0K
$130.0K
$205.0K
$423.0K
$907.0K
$27.0K
$29.0K
·
·
$14M
$89.0K
$86.0K
$87.0K
Deferred Tax
$-20.0K
$30.0K
$-40.0K
$-16.0K
$3.0K
$6.0K
$9.0K
$22.0K
$2.0K
$29.0K
$-77.0K
$-1.0K
·
·
Operating Cash Flow
$-2M
$-2M
$-2M
$-2M
$-804.0K
$-3M
$-3M
$-13M
$-303.0K
$492.0K
$-3M
$-198.9K
$49.7K
$-418.0K
CapEx
$251.0K
$121.0K
$363.0K
$339.0K
$494.0K
$435.0K
$1M
$488.0K
$541.0K
$571.0K
$116.0K
$423.0K
$466.0K
$537.0K
Investing Cash Flow
$-251.0K
$-101.0K
$-363.0K
$-339.0K
$-485.0K
$-420.0K
$-1M
$-488.0K
$-541.0K
$-571.0K
$-116.0K
$-105M
$-1M
$-507.0K
Stock Issued
·
·
·
$34.0K
$82.0K
$5M
·
$22M
·
·
·
·
·
·
Financing Cash Flow
$1M
$-24.0K
$26M
$-36.0K
$-266.0K
$4M
$-1.0K
$22M
$587.0K
$-585.0K
$4M
$105M
$1M
$350.0K
Net Change in Cash
$-2M
$-2M
$23M
$-2M
$-2M
$389.0K
$-4M
$8M
$-257.0K
$-664.0K
$642.0K
$-174.2K
$712.3K
$-575.0K
Taxes Paid
$0
$10.0K
$-37.0K
$0
$0
$110.0K
$0
·
·
·
·
·
$4.0K
$27.0K
Free Cash Flow
·
$-2M
·
·
·
$-4M
·
·
·
$-79.0K
·
·
·
·
Profitability7
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Operating Margin
-153.4%
-160.7%
·
-107.6%
-233.8%
-394.6%
·
-541.5%
-228.1%
-112.8%
·
·
·
·
Net Margin
-145.1%
-153.1%
·
-106.5%
-234.1%
-379.2%
·
-511.6%
-300.9%
-172.4%
·
·
·
·
Pretax Margin
-146.0%
-151.0%
·
-107.2%
-233.4%
-378.5%
·
-536.2%
-300.3%
-171.0%
·
·
·
·
EBITDA Margin
-153.4%
-160.7%
·
-107.6%
-233.8%
-394.6%
·
-541.5%
-228.1%
-112.8%
·
·
·
·
ROA
-10.2%
-10.0%
·
-10.9%
-21.4%
-29.1%
·
-44.7%
-37.7%
-5.9%
·
-1.4%
-1.4%
0.42%
ROE
-12.9%
-11.6%
·
-14.0%
-58.8%
-62.1%
·
-126.5%
-5777.2%
-773.9%
·
93.1%
352.0%
143.6%
ROIC
-9.1%
-8.8%
·
-20.3%
-34.1%
-35.8%
·
-53.0%
-312.9%
-190.0%
·
16.1%
36.2%
99.0%
Liquidity & Solvency2
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Current Ratio
7.2
13.0
·
2.0
2.0
3.4
·
4.7
0.6
0.8
·
·
·
·
Quick Ratio
6.1
10.8
·
0.5
0.9
1.7
·
3.1
0.1
0.1
·
·
·
·
Efficiency2
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Asset Turnover
0.1
0.1
·
0.1
0.1
0.1
·
0.1
0.1
0.0
·
·
·
·
Receivables Turnover
0.8
1.6
·
2.0
1.5
1.5
·
4.1
4.1
6.7
·
·
·
·
Per Share5
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Book Value / Share
$12.92
$14.77
·
$0.24
$0.29
$0.39
·
$0.51
$0.11
$0.11
·
·
·
·
Revenue / Share
$0.82
$0.80
·
$0.05
$0.04
$0.04
·
$0.07
$0.16
$0.19
·
·
·
·
Cash Flow / Share
·
$-0.84
·
·
·
$-0.10
·
·
·
$0.04
·
·
·
·
Cash / Share
$9.52
$11.21
·
$0.03
$0.09
$0.14
·
$0.28
$0.02
$0.04
·
·
·
·
EPS (TTM)
$-2.49
$-5.26
·
$-9.36
$-9.65
$-6.16
·
$5.64
$2.50
$1.76
·
·
·
·
Valuation (TTM)9
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Revenue TTM
$6M
$6M
·
$6M
$6M
$6M
·
$8M
$8M
$7M
·
·
·
·
Net Income TTM
$-9M
$-10M
·
$-12M
$-19M
$-22M
·
$-35M
$-29M
$-23M
·
$-19M
$-17M
$-16M
Market Cap
$103.4K
$94.4K
·
·
·
·
·
·
·
·
·
·
·
·
P/E
-0.0
-0.0
·
·
·
·
·
·
·
·
·
·
·
·
P/S
0.0
0.0
·
·
·
·
·
·
·
·
·
·
·
·
P/B
0.0
0.0
·
·
·
·
·
·
·
·
·
·
·
·
P / Tangible Book
0.0
0.0
·
·
·
·
·
·
·
·
·
·
·
·
P / Cash Flow
·
-0.1
·
·
·
·
·
·
·
·
·
·
·
·
Earnings Yield
-5309.2%
-11215.3%
·
·
·
·
·
·
·
·
·
·
·
·
Most recent period on the left · null values shown as ·
Financial Statements
Income statement, balance sheet, cash flow — annual, last 5 years
16
Metric
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Revenue
$6M
$7M
$5M
$7M
·
Operating Margin %
-216.4%
-255.1%
-396.6%
·
·
Net Income
$-12M
$-21M
$-22M
$-13M
·
Diluted EPS
$-0.31
$-1.07
$-3.56
$-2.51
·
Metric
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Debt / Equity
0.0
·
·
·
·
Current Ratio
11.7
3.5
1.2
·
·
Quick Ratio
9.8
1.7
0.3
·
·
Metric
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Free Cash Flow
$-10M
$-18M
$-6M
·
·
Institutional owners (13F)
21 filers
· $574K total
· As of June 30, 2026
17
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders21
Value held$574K
New positions1
Exited positions1
Institutional activity — Q2 2026 vs prior quarter
New positions
Exited positions
Increased
Decreased
Net shares change
1 (0 vs prior Q)
1 (+1 vs prior Q)
0 (0 vs prior Q)
2 (-1 vs prior Q)
+113K
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.